&PARTNERS Buys 35,572 Shares of Procter & Gamble Company (The) $PG

&PARTNERS increased its stake in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 7.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 524,020 shares of the company’s stock after purchasing an additional 35,572 shares during the quarter. &PARTNERS’s holdings in Procter & Gamble were worth $75,070,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Triodos Investment Management BV lifted its stake in Procter & Gamble by 7.3% in the third quarter. Triodos Investment Management BV now owns 255,095 shares of the company’s stock valued at $39,195,000 after buying an additional 17,400 shares during the period. Gradient Investments LLC increased its stake in Procter & Gamble by 12.8% in the fourth quarter. Gradient Investments LLC now owns 253,089 shares of the company’s stock valued at $36,270,000 after purchasing an additional 28,777 shares in the last quarter. Fiera Capital Corp raised its holdings in Procter & Gamble by 20.3% in the third quarter. Fiera Capital Corp now owns 53,128 shares of the company’s stock worth $8,163,000 after purchasing an additional 8,961 shares during the period. Arete Wealth Advisors LLC bought a new position in shares of Procter & Gamble during the third quarter worth $3,776,000. Finally, Cibc World Market Inc. grew its holdings in shares of Procter & Gamble by 40.6% in the 4th quarter. Cibc World Market Inc. now owns 511,833 shares of the company’s stock valued at $73,351,000 after buying an additional 147,701 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Stock Up 1.3%

Procter & Gamble stock opened at $152.38 on Wednesday. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $167.25. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.73 and a quick ratio of 0.53. The firm has a market capitalization of $354.83 billion, a PE ratio of 22.28, a P/E/G ratio of 6.54 and a beta of 0.39. The company’s 50-day moving average is $144.96 and its 200-day moving average is $147.75.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings results on Friday, April 24th. The company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.56 by $0.03. Procter & Gamble had a return on equity of 32.00% and a net margin of 19.16%.The firm had revenue of $21.24 billion for the quarter, compared to the consensus estimate of $21.52 billion. During the same quarter in the previous year, the business earned $1.54 earnings per share. The business’s revenue was up 7.4% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Sell-side analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Friday, April 24th were given a $1.0885 dividend. The ex-dividend date of this dividend was Friday, April 24th. This is a boost from Procter & Gamble’s previous quarterly dividend of $1.06. This represents a $4.35 annualized dividend and a dividend yield of 2.9%. Procter & Gamble’s payout ratio is currently 63.60%.

Analysts Set New Price Targets

PG has been the topic of several research analyst reports. Rothschild & Co Redburn dropped their price objective on Procter & Gamble from $157.00 to $155.00 and set a “neutral” rating on the stock in a research note on Monday, April 27th. Wells Fargo & Company increased their price objective on shares of Procter & Gamble from $158.00 to $164.00 and gave the stock an “overweight” rating in a research report on Monday, April 27th. Weiss Ratings restated a “hold (c)” rating on shares of Procter & Gamble in a report on Friday, March 27th. Morgan Stanley reduced their price objective on Procter & Gamble from $175.00 to $166.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Finally, Erste Group Bank downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a report on Tuesday, March 24th. Eleven research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $160.78.

Get Our Latest Stock Report on PG

Procter & Gamble Profile

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.